Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rodent models and accompanying in vitro strategies for studying the etiology and therapy of Parkinson's disease.

Journal of Parkinson's disease·2026
Same author

The road towards faster development of novel pharmacotherapies for persons with Parkinson's disease.

Journal of Parkinson's disease·2026
Same author

Progression of Dysarthria, Drooling, and Swallowing Disorders in Parkinson's Disease: A 1-Year Prospective Cohort Study.

American journal of speech-language pathology·2026
Same author

Disease modification in advanced Parkinson's disease: a review and roadmap for paving the way for next-generation interventions.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Neuroinflammatory profiles and cellular localization of TNF-α associated with chronic vanadium neurotoxicity.

Metabolic brain disease·2026
Same author

Prion 2025: advancing the understanding and treatment of prion diseases in dialogue with patients and families.

Prion·2026

Related Experiment Video

Updated: Apr 2, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.8K

A Systematic Comparison of Alpha-Synuclein Seed Amplification Assays for Increasing Reproducibility.

Manuela Amaral-do-Nascimento1, Daniela F Santos2, Tuane C R G Vieira1,2

  • 1Instituto de Bioquímica Médica, Instituto Nacional de Ciência e Tecnologia de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Annals of Clinical and Translational Neurology
|April 1, 2026
PubMed
Summary

Seed amplification assays (SAAs) offer sensitive detection of alpha-synuclein. Standardizing these assays is crucial for reliable research and clinical use, requiring defined protocols and quality controls.

Keywords:
RT‐QuICalpha‐synucleinbiomarkerseed amplification assaysynucleinopathies

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.2K
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K

Related Experiment Videos

Last Updated: Apr 2, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.8K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.2K
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K

Area of Science:

  • Biochemistry
  • Neuroscience
  • Assay Development

Background:

  • Seed amplification assays (SAAs) detect misfolded alpha-synuclein (α-syn) in biological samples.
  • Current SAA protocols vary, hindering consistent results and clinical application.

Purpose of the Study:

  • To review alpha-synuclein SAA methods and performance.
  • To identify key variables impacting assay outcomes.
  • To propose a framework for standardization and quality control.

Main Methods:

  • Literature review of alpha-synuclein SAA methodologies.
  • Cataloging of critical analytical variables (e.g., protein variants, buffers, salts, shaking, temperature).
  • Identification of pre-analytical factors influencing assay results.

Main Results:

  • SAA protocol heterogeneity is a major barrier to comparability.
  • Key variables influencing reproducibility and clinical interpretation were identified.
  • A framework for prioritizing analytical and pre-analytical factors was proposed.

Conclusions:

  • Standardized alpha-synuclein SAAs are essential for clinical translation.
  • Minimal reporting criteria and quality control checkpoints are recommended.
  • Multicenter proficiency testing is vital for robust implementation.